Skip to main content

Table 1 Preoperative recipient-related data

From: Impact of patent foramen ovale on short-term outcomes in children with biliary atresia undergoing living donor liver transplantation: a retrospective cohort study

Variable

PFO (n = 73)

NoPFO (n = 231)

P-Value

Age (m)

6(6–8)

9(6–15)

< 0.001

Male gender (%)

32(43.8%)

119(51.5%)

0.253

Height (cm)

65(61–68)

68(64–80)

< 0.001

Weight (kg)

6.5(6.0–7.0)

8.0(6.6–10.8)

< 0.001

PELD score

21(13–27)

16(5–23)

0.001

LVEF (%)

65(61–67)

64(62–67)

0.773

ALT (U/L)

95(71–175)

104(63–168)

0.861

AST (U/L)

208(122–336)

185(118–292)

0.241

Total Bilirubin (µmol/L)

247(147–352)

202(65–307)

0.007

INR

1.41(1.19–1.92)

1.37(1.12–1.78)

0.136

Creatinine (µmol/L)

13.0(12.0–15.0)

14.0(11.0-16.5)

0.538

Hemoglobin (g/dL)

92.4 ± 15.1

93.0 ± 16.9

0.79

  1. LVEF, left ventricular ejection fraction; PELD, pediatric end-stage liver disease; ALT, alanine aminotransferase; AST, aspartate aminotransferase; INR, international normalized ratio